Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis
- 1 January 2015
- journal article
- review article
- Published by Elsevier in Fertility and Sterility
- Vol. 103 (1) , 119-130.e3
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approachHuman Reproduction Update, 2013
- The ageing ovary and uterus: new biological insightsHuman Reproduction Update, 2012
- The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustmentsHuman Reproduction, 2012
- Correlation of serum Anti-Müllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patientsJournal of Assisted Reproduction and Genetics, 2012
- Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserveFertility and Sterility, 2010
- Serum antimüllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproductionFertility and Sterility, 2010
- Variations in serum müllerian inhibiting substance between white, black, and Hispanic womenFertility and Sterility, 2009
- Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cyclesReproductive Biology and Endocrinology, 2009
- Anti-Müllerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilizationFertility and Sterility, 2008
- Measuring inconsistency in meta-analysesBMJ, 2003